Surmodics reported $32M in Operating Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8869M 114M
Align Technology ALGN:US $ 781.36M 6.22M
Anika Therapeutics ANIK:US $ 43.04M 2.79M
Arrowhead Research ARWR:US $ 105.32M 4.93M
Baxter International BAX:US $ 3395M 149M
Bioscrip BIOS:US $ 921.74M 58.2M
Boston Scientific BSX:US $ 2821M 261M
Cryolife CRY:US $ 75.8M 252K
Edap Tms EDAP:US 14.51M 993.12K
Edwards Lifesciences EW:US $ 914.4M 12M
Haemonetics HAE:US $ 230.69M 15.11M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Johnson & Johnson JNJ:US $ 18.18B 616M
Merit Medical Systems MMSI:US $ 271.72M 11.54M
Mesa Laboratories MLAB:US $ 55.05M 3.94M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Stryker SYK:US $ 3.72B 107M
Surmodics SRDX:US $ 32M 991K
Trinity Biotech TRIB:US 28.88M 9.94M